EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Versant Ventures partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe, harnessing the power of science to deliver strong results since 1999.
Dayra Therapeutics Secures Over $70M in Committed Funding
Gate Bioscience Raises $65M in Series B Financing
Gate Bioscience Secures $65M Series B Round Led by Forbion and Eli Lilly
Dayra Therapeutics Raises Over $70M in Funding From Biogen and Versant Ventures